Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.
about
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnologyMesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent.Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Hybrid nanoparticles for combination therapy of cancerRelating Nanoparticle Properties to Biological Outcomes in Exposure Escalation ExperimentsMesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibilityPhysicochemical properties determine nanomaterial cellular uptake, transport, and fateNanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approachFunctionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitroEnhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell linesComposite nanoparticles for gene delivery.Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugsSurface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells.Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells.Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems.Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.Micropatterning of silica nanoparticles by electrospray deposition through a stencil mask.Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activationPhotoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublinesTOXICITY PROFILING OF ENGINEERED NANOMATERIALS VIA MULTIVARIATE DOSE-RESPONSE SURFACE MODELING.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.Mass spectrometry-based tissue imaging of small moleculesNanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cellsCo-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug ReleaseSynthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.NIR photoregulated chemo- and photodynamic cancer therapy based on conjugated polyelectrolyte-drug conjugate encapsulated upconversion nanoparticles.Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine.
P2860
Q26849264-7928CFA9-E589-469B-A4F5-310E0E20D54DQ27317754-F75A28DF-C446-4A65-8EAF-37D09BF6273FQ28073956-BF0497B5-E10E-4D39-873F-4A9885A6CE38Q28086815-2305F4B5-233A-4F7A-AAB1-533E6471C43BQ28384365-8155AEAF-D07F-440C-8903-171F54B9C144Q28384598-CEB76948-0456-4DE4-8BB2-961EB4A28D99Q28392819-EEB30DE1-6577-45C5-86A3-AD98A07F4745Q28485257-B47062EE-1757-45ED-89B8-5E691DB7CF23Q28488394-8B02D41D-F068-420D-B426-245E7382DFD1Q28546881-EF8C6581-139E-49D8-A7DF-434522F33D8CQ30374988-56125164-988A-4B82-B67B-CF7312B2884DQ30399655-2E522F63-BA22-4AE9-A82F-584958509EFDQ30439353-DA1F9940-9994-4969-BDD4-4B643D8A8CD7Q30451813-B54C0CFB-218B-422A-8128-916FFEC9CFCCQ30458534-92D7EE53-E6B1-4949-AA36-AE8E893D9BFCQ30468502-1100EB1F-8A03-42C6-9379-7C71C84D1BFDQ30501687-DE0CC10C-19E4-4A38-9A74-75FB6CA8826CQ30524254-F7EBD548-E782-4328-8105-80CF77D97CD4Q33458507-68F4C320-32BF-44E7-9AF9-DAF800B1DC20Q33561078-5C2BC95C-DA7B-4611-9CA5-7310A9D40370Q33635355-9AF77BDC-37BE-4810-8F12-496B50F6FB8DQ33705552-9ED8C3BE-633A-4D7C-AD66-55275BD2296FQ33862903-DDD0EA49-B65F-4429-A8EF-DA9630BB77C5Q33935474-3D927DD6-4073-49DF-B5B2-04B507AA0DB9Q33993918-69011885-856C-4382-8411-821894138D6FQ34011106-80B516CF-CCD2-49CE-BC7D-2A1BE8D26E86Q34056422-7C20FF7E-F5E1-4231-BAC8-F09E5F5A13FBQ34121124-BF0A318A-9F02-4B8F-AFB2-7EA7560AC5D6Q34135640-9CFAE4D3-145A-4DA9-A275-D03B86C5FEF6Q34237712-9AB0080A-1DDE-4775-9DD3-2B903146923FQ34279939-28173EA9-B7AC-4F0F-AC5E-9262C5E110A8Q34408036-A53C7651-5CFE-4C03-A924-6A928EE7D383Q34435737-63120F4E-719A-4ABA-9963-01C3838AE079Q34446374-C687B236-1977-45C1-AA2B-69CCEF22DD16Q34622662-586BFBDC-2C79-4DBD-B077-AED5A02C8C5CQ34823319-63002189-07B6-4BB3-8F15-29B68029A402Q34986234-2AB944C7-0F44-4498-9B8D-762E7402F6CFQ35162222-A6782073-3E0A-44C1-9A03-4089FA95E6B4Q35226499-91A1648F-E18E-480E-A82B-2194537CFF1FQ35387777-0F0FF9EB-AD84-4D65-A384-1C4760A23CE2
P2860
Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Engineered design of mesoporou ...... istance in a cancer cell line.
@en
Engineered design of mesoporou ...... istance in a cancer cell line.
@nl
type
label
Engineered design of mesoporou ...... istance in a cancer cell line.
@en
Engineered design of mesoporou ...... istance in a cancer cell line.
@nl
prefLabel
Engineered design of mesoporou ...... istance in a cancer cell line.
@en
Engineered design of mesoporou ...... istance in a cancer cell line.
@nl
P2093
P2860
P921
P356
P1433
P1476
Engineered design of mesoporou ...... istance in a cancer cell line.
@en
P2093
Andre E Nel
Jeffrey I Zink
Monty Liong
Zhaoxia Ji
P2860
P304
P356
10.1021/NN100690M
P407
P50
P577
2010-08-01T00:00:00Z